March 13, 2019 03:24 AM Eastern Daylight Time

BUSINESS WIRE

Flow Pharma, Inc. und OncoImmunity AS bilden Partnerschaft zur Entwicklung von personalisierten Krebsimpfstoffen der Marke FlowVaxTM.

http://www.flowpharma.com/

http://www.flowpharma.com/

Opens in new window

Download

Full Size JPEG, 2461x671, 172.8 KB
Small JPEG, 480x131, 22.1 KB
Preview JPEG, 144x39, 3.8 KB
Thumbnail JPEG, 72x20, 1.6 KB

Smart Multimedia Gallery

http://www.flowpharma.com/

http://www.flowpharma.com/

http://www.businesswire.it/multimedia/it/20190313005264/de/4537291/

View and Share Logo

Share

Email

All News | News with Multimedia > Press Release: Flow Pharma, Inc. und OncoImmunity AS bilden Pa...